FWM
RMD icon

FFT Wealth Management’s ResMed RMD Stock Holding History

FFT Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,357
Closed -$1.41M – 93
2021
Q3 		$1.41M Buy
5,357
+5,213
+3,620% +$1.43M 0.13% 31
2021
Q2 		$35K Buy
+144
New +$30.3K 0.01% 147

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

FFT Wealth Management's RMD Position: Q4 2021 in Review

FFT Wealth Management sold out of ResMed (RMD) in Q4 2021, closing a stake of 5,357 shares — an estimated $1.41M sold.

FFT Wealth Management first reported a position in RMD in Q2 2021 and held it in 2 quarters. The position peaked at $1.41M in Q3 2021. 724 funds tracked by Wall St. Rank hold RMD as of Q4 2021.

  • FFT Wealth Management reported no remaining ResMed position as of Q4 2021 after selling out during the quarter.
  • FFT Wealth Management sold 5,357 ResMed shares in Q4 2021, an estimated $1.41M.
  • FFT Wealth Management first reported a position in ResMed in Q2 2021 and held it in 2 quarters.
  • FFT Wealth Management's ResMed position peaked at $1.41M in Q3 2021.
  • 724 funds tracked by Wall St. Rank held ResMed as of Q4 2021.

Based on FFT Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.